Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
8161.HK Stock Summary
In the News
8161.HK Financial details
Company Rating
Buy
Market Cap
18.3M
Income
-27.11M
Revenue
109.75M
Book val./share
0.23
Cash/share
0.48
Dividend
-
Dividend %
-
Employees
89
Optionable
No
Shortable
Yes
Earnings
09 Feb 2024
P/E
-0.68
Forward P/E
-
PEG
-0.02
P/S
0.17
P/B
1.96
P/C
0.92
P/FCF
-
Quick Ratio
0.54
Current Ratio
0.87
Debt / Equity
1.8
LT Debt / Equity
0.3
-
-
EPS (TTM)
-0.65
EPS next Y
-
EPS next Q
-
EPS this Y
300%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
13.4%
Revenue last 5Y
-4.75%
Revenue Q/Q
-0.59%
EPS Q/Q
36.36%
-
-
-
-
SMA20
-4.35%
SMA50
41.94%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-56%
ROE
-512%
ROC
-2.27%
Gross Margin
49%
Oper. Margin
-25%
Profit Margin
-25%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.25-0.63
52W High
-
52W Low
-
RSI
53.98
Rel Volume
-
Avg Volume
873
Volume
Perf Week
-1.12%
Perf Month
10%
Perf Quarter
-
Perf Half Y
76%
-
-
-
-
Beta
0.812
-
-
Volatility
0%, 0.02%
Prev Close
0%
Price
0.44
Change
0%
8161.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.39 | 3.48 | 3.11 | 2.91 | 2.65 | |
Net income per share | -0.32 | -0.36 | 0.11 | -0.15 | -0.6 | |
Operating cash flow per share | -0.07 | 0.12 | 0.45 | 0.17 | 0.25 | |
Free cash flow per share | -0.16 | 0.06 | 0.4 | 0.16 | 0.23 | |
Cash per share | 0.66 | 0.38 | 0.5 | 0.38 | 0.37 | |
Book value per share | 1.28 | 0.92 | 1.03 | 0.88 | 0.28 | |
Tangible book value per share | 0.66 | 0.34 | 0.49 | 0.37 | 0.18 | |
Share holders equity per share | 1.28 | 0.92 | 1.03 | 0.88 | 0.28 | |
Interest debt per share | -0.34 | 0.3 | 0.36 | 0.32 | 0.25 | |
Market cap | 72.8M | 58.24M | 67.81M | 45.76M | 12.48M | |
Enterprise value | 45.31M | 54.19M | 61.4M | 43.01M | 6.73M | |
P/E ratio | -5.42 | -3.9 | 14.26 | -7.36 | -0.5 | |
Price to sales ratio | 0.52 | 0.4 | 0.52 | 0.38 | 0.11 | |
POCF ratio | -25.81 | 12.11 | 3.65 | 6.34 | 1.2 | |
PFCF ratio | -11.13 | 23.57 | 4.1 | 7.09 | 1.29 | |
P/B Ratio | 1.37 | 1.52 | 1.58 | 1.24 | 1.06 | |
PTB ratio | 1.37 | 1.52 | 1.58 | 1.24 | 1.06 | |
EV to sales | 0.32 | 0.37 | 0.47 | 0.36 | 0.06 | |
Enterprise value over EBITDA | 3.19 | 5.39 | 3.12 | 5.8 | -0.59 | |
EV to operating cash flow | -16.06 | 11.27 | 3.3 | 5.95 | 0.65 | |
EV to free cash flow | -6.93 | 21.93 | 3.71 | 6.67 | 0.7 | |
Earnings yield | -0.18 | -0.26 | 0.07 | -0.14 | -1.99 | |
Free cash flow yield | -0.09 | 0.04 | 0.24 | 0.14 | 0.77 | |
Debt to equity | -0.27 | 0.31 | 0.33 | 0.35 | 0.84 | |
Debt to assets | -0.17 | 0.16 | 0.19 | 0.19 | 0.23 | |
Net debt to EBITDA | -1.93 | -0.4 | -0.33 | -0.37 | 0.51 | |
Current ratio | 1.32 | 1.06 | 1.17 | 1.03 | 0.91 | |
Interest coverage | 0 | -8.2 | 0.64 | -10.9 | -18.78 | |
Income quality | 0.23 | -0.34 | 3.92 | -1.07 | -0.41 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.3 | 0.33 | 0.3 | 0.31 | 0.04 | |
Capex to operating cash flow | 1.32 | -0.49 | -0.11 | -0.11 | -0.07 | |
Capex to revenue | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | |
Capex to depreciation | -0.83 | -0.15 | -0.14 | -0.05 | -0.05 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.05 | 2.73 | 1.63 | 1.72 | 1.95 | |
ROIC | -0.27 | -0.1 | 0.01 | -0.11 | -0.33 | |
Return on tangible assets | -0.22 | -0.31 | 0.09 | -0.13 | -0.61 | |
Graham Net | 0.08 | -0.26 | -0.16 | -0.23 | -0.23 | |
Working capital | 10.18M | 1.55M | 4.39M | 844K | -2.4M | |
Tangible asset value | 27.48M | 14.04M | 20.42M | 15.58M | 9.42M | |
Net current asset value | 8.93M | -5.64M | -2.44M | -5.2M | -6.26M | |
Invested capital | -0.27 | 0.31 | 0.33 | 0.35 | 0.84 | |
Average receivables | 5.46M | 10.09M | 8.12M | 7.73M | 8.37M | |
Average payables | 9.71M | 8.59M | 5.8M | 5.13M | 6.55M | |
Average inventory | 736.5K | 920.5K | 872K | 572.5K | 428.5K | |
Days sales outstanding | 28.32 | 23.29 | 19.71 | 25.5 | 27.38 | |
Days payables outstanding | 51.78 | 31.23 | 32.96 | 32.47 | 55.41 | |
Days of inventory on hand | 3.57 | 5.42 | 4.04 | 3.23 | 2.48 | |
Receivables turnover | 12.89 | 15.67 | 18.52 | 14.31 | 13.33 | |
Payables turnover | 7.05 | 11.69 | 11.07 | 11.24 | 6.59 | |
Inventory turnover | 102.36 | 67.35 | 90.24 | 113.07 | 147.15 | |
ROE | -0.25 | -0.39 | 0.11 | -0.17 | -2.12 | |
Capex per share | -0.09 | -0.06 | -0.05 | -0.02 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.73 | 0.6 | 0.65 | 0.7 | 0.7 | |
Net income per share | 0 | -0.12 | -0.48 | -0.02 | -0.03 | |
Operating cash flow per share | 0.21 | 0 | 0.04 | 0 | 0.02 | |
Free cash flow per share | 0.2 | 0 | 0.04 | 0 | -0.01 | |
Cash per share | 0.48 | 0.48 | 0.37 | 0.37 | 0.48 | |
Book value per share | 0.89 | 0.89 | 0.28 | 0.27 | 0.23 | |
Tangible book value per share | 0.4 | 0 | 0.18 | 0 | 0.12 | |
Share holders equity per share | 0.89 | 0.89 | 0.28 | 0.27 | 0.23 | |
Interest debt per share | 0.3 | 0 | 0.24 | 0 | 0.41 | |
Market cap | 16.02M | 14.14M | 12.48M | 16.43M | 11.02M | |
Enterprise value | 8.3M | 34.12M | 6.73M | 32.01M | 8.04M | |
P/E ratio | -26.69 | -0.7 | -0.16 | -4.28 | -2.1 | |
Price to sales ratio | 0.53 | 0.57 | 0.46 | 0.56 | 0.38 | |
POCF ratio | 1.82 | 0 | 8.04 | 0 | 15.57 | |
PFCF ratio | 1.97 | 0 | 8.11 | 0 | -17.75 | |
P/B Ratio | 0.43 | 0.38 | 1.06 | 1.45 | 1.17 | |
PTB ratio | 0.43 | 0.38 | 1.06 | 1.45 | 1.17 | |
EV to sales | 0.27 | 1.38 | 0.25 | 1.1 | 0.28 | |
Enterprise value over EBITDA | 2.47 | -19.75 | -0.4 | 20.58 | 9 | |
EV to operating cash flow | 0.94 | 0 | 4.33 | 0 | 11.36 | |
EV to free cash flow | 1.02 | 0 | 4.37 | 0 | -12.95 | |
Earnings yield | -0.01 | -0.35 | -1.59 | -0.06 | -0.12 | |
Free cash flow yield | 0.51 | 0 | 0.12 | 0 | -0.06 | |
Debt to equity | 0.33 | 0 | 0.84 | 0 | 1.8 | |
Debt to assets | 0.18 | 0 | 0.23 | 0 | 0.35 | |
Net debt to EBITDA | -2.3 | -11.56 | 0.34 | 10.02 | -3.34 | |
Current ratio | 1.08 | 0 | 0.91 | 0 | 0.87 | |
Interest coverage | -0.63 | -39.09 | -173.82 | -10.88 | -6.86 | |
Income quality | -195.96 | 0 | -0.06 | 0 | -0.31 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.29 | 0 | 0.04 | 0 | 0.04 | |
Capex to operating cash flow | -0.08 | 0 | -0.01 | 0 | -1.88 | |
Capex to revenue | -0.02 | 0 | 0 | 0 | -0.05 | |
Capex to depreciation | -0.1 | 0 | 0 | 0 | -0.3 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.27 | 1.55 | 1.74 | 0.38 | 0.4 | |
ROIC | 0 | -0.14 | -0.63 | -0.11 | -0.03 | |
Return on tangible assets | 0 | 0 | -0.48 | 0 | -0.03 | |
Graham Net | -0.17 | 0.48 | -0.23 | 0.37 | -0.29 | |
Working capital | 2.27M | 19.98M | -2.4M | 15.57M | -4.78M | |
Tangible asset value | 16.58M | 0 | 9.42M | 0 | 7.1M | |
Net current asset value | -3.21M | 19.98M | -6.26M | 15.57M | -7.77M | |
Invested capital | 0.33 | 0 | 0.84 | 0 | 1.8 | |
Average receivables | 3.76M | 3.76M | 4.14M | 4.14M | 5.11M | |
Average payables | 1.4M | 1.4M | 4.08M | 4.08M | 5.1M | |
Average inventory | 193K | 193K | 182.5K | 182.5K | 263.5K | |
Days sales outstanding | 22.3 | 0 | 27.69 | 0 | 31.76 | |
Days payables outstanding | 18.32 | 0 | 55.23 | 0 | 60.96 | |
Days of inventory on hand | 2.53 | 0 | 2.47 | 0 | 3.15 | |
Receivables turnover | 4.04 | 0 | 3.25 | 0 | 2.83 | |
Payables turnover | 4.91 | 0 | 1.63 | 0 | 1.48 | |
Inventory turnover | 35.58 | 0 | 36.4 | 0 | 28.57 | |
ROE | 0 | -0.14 | -1.69 | -0.08 | -0.14 | |
Capex per share | -0.02 | 0 | 0 | 0 | -0.03 |
8161.HK Frequently Asked Questions
What is MediNet Group Limited stock symbol ?
MediNet Group Limited is a HK stock and trading under the symbol 8161.HK
What is MediNet Group Limited stock quote today ?
MediNet Group Limited stock price is $0.44 today.
Is MediNet Group Limited stock public?
Yes, MediNet Group Limited is a publicly traded company.